-
-
Anti-PCSK9 Reference Antibody (Boehringer anti-PCSK9),, 50 микрограмм
-
Anti-PCSK9 Reference Antibody (ebronucimab),, 50 микрограмм
-
Anti-PCSK9 Reference Antibody (bococizumab),, 50 микрограмм
-
Anti-PCLA Reference Antibody (U.Penn. patent anti-PCLA),, 50 микрограмм
-
Anti-PCSK9 Reference Antibody (alirocumab),, 50 микрограмм
-
Anti-PAR2 Reference Antibody (Regeneron patent anti-PAR-2),, 50 микрограмм
-
Anti-PAR2 Reference Antibody (Amgen patent anti-PAR-2),, 50 микрограмм
-
Anti-PAR2 Reference Antibody (PAR650097),, 50 микрограмм
-
Anti-PACAP38 Reference Antibody (Lilly patent anti-PACAP),, 50 микрограмм
-
Anti-P-Selectin / CD62p Reference Antibody (inclacumab),, 50 микрограмм
-
Anti-PAC1 Reference Antibody (zelminemab),, 50 микрограмм
стр.: